Union Health Ministry has urged states and Union Territories to constitute Block Task Force (BTF) to further decentralise planning and preparedness for the roll-out of the...
According to experts, a vaccine's effectiveness can be influenced by multiple factors like the rate of spread of a virus, number of people adhering to the...
Russia had ealier announced that the Sputnik V vaccine will be priced at $10 per dose in international markets, costing less than some other registered COVID-19...
According to AstraZeneca CEO, the company might launch a fresh study to evaluate a lower dosage of its COVID-19 vaccine candidate that performed better than a...
Pharmaceutical company AstraZeneca has acknowledged a key mistake in the COVID-19 vaccine dosage received by some study participants
According to State Immunisation Officer Suresh Seth, there are 600 cold storage points and around 1,800 outreach sites for the universal immunisation programme for children in...
Dr M V Padma Srivastava, the chief of Neurosciences Centre, AIIMS said that anti-coronavirus vaccine 'Covaxin' being developed by Bharat Biotech in collaboration with the Indian...
In a conversation with NDTV, Dr. Soumya Swaminathan, Chief Scientist at WHO said that while vaccine candidates showing efficacy results in the range of 90 per...
With vaccines in the advance stages of development showing encouraging results raising hopes of billions of people as a way back to normalcy, the question arises,...
In U.K., the Oxford COVID-19 vaccine proved to be 90 per cent efficacious if administered at a half dose and then at a full dose
Oxford’s COVID-19 vaccine that will be called Covishield in India has produced 90 per cent immune response in one type of the dosage regimen
Dr Reddy's Laboratories in India has collaborated with Russian Direct Investment Fund to conduct mid to late-stage human trials for the Sputnik V vaccine candidate in...